Navigation Links
Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
Date:7/31/2008

from a Phase 1 clinical trial of picoplatin combined with liposomal doxorubicin in patients with advanced solid tumors, including ovarian cancer. Results demonstrated robust signals of clinical efficacy in ovarian cancer patients and acceptable toxicity with this combination.

-- Oral Picoplatin: Presented results at the Annual Meeting of the American Association for Cancer Research (AACR) in April, from our ongoing Phase 1 clinical trial of oral picoplatin in patients with advanced solid tumors. Data from this trial showed that picoplatin can achieve oral bioavailability at levels that support further clinical development of this dosage form.

-- Platinum Resistance: Announced at the AACR Annual Meeting expanded preclinical data indicating that picoplatin retained its anti-tumor activity in SCLC cells resistant to previous treatment with cisplatin, carboplatin or oxaliplatin. These data support the property of picoplatin to overcome platinum resistance induced by currently available platinum agents.

In additional, we announced in April an agreement with AltheaDx to use its Express Pathway platform to identify molecular signatures that may be correlated with platinum resistance. The identification of molecular signatures of platinum resistance may lead to the development of biomarkers for platinum resistance.

Pipeline Development

-- Executed an agreement with The Scripps Research Institute licensing classes of protein kinase inhibitors for the treatment of human diseases, including cancer. The research collaboration was initiated in 2005 at Scripps Florida, a division of the Institute located in Palm Beach County, and later broadened to include The Scripps Research Institute, La Jolla, Calif. The license includes compounds that were discovered by Scripps Research in collaboration with Poniard.

Clinical Advisory Board

-- Appointed four additional members to the Clinical Advisory Board to help guide the expanding clinical
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Connecticut (PRWEB) July 30, 2014 Pain ... new magnetic sports bracelet for pain relief and improved ... strength carbonized titanium embedded in a silicone core that ... also has Germanium and is embedded with scalar energy ... bracelet. , “Pain Free Living has 12 years experience ...
(Date:7/29/2014)... July 29, 2014 Paul Mata, CEO of ... More Money in 30 Days” E-book. The e-book includes a ... to make extra cash. Examples include downloading and utilizing specific ... websites that help people monetize the assets they didn't know ... items they can find in their garage. , After ...
(Date:7/29/2014)... 29, 2014 1Heart Caregiver Services’ ... with focus on Brain Fitness Education brings great ... Brain Fitness Program Director Tee Barr delivered an ... Care unit and the Assisted Living section of ... Enrichment Director Christy Rozsa and Aegis Life Neighborhood ...
(Date:7/29/2014)... Daily Gossip indicates that the new method can ... that hemorrhoids commonly causes. The new method was developed ... , The author of H Miracle reveals that ... such as itching, burning, pain and swelling, as well ... Miracle by visiting the official website at: http://www.dailygossip.org/cure-hemorrhoids-in-48-hours-review-6851 ...
(Date:7/29/2014)... 2014 The One Minute Herpes Cure review ... an herbal medicine specialist. Alison Freeman wanted to show her ... , People interested in finding out more about this method ... it, as it is currently available in online format. , ... remedies and herbal medicine tips that can help them achieve ...
Breaking Medicine News(10 mins):Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Create Indestructible Wealth Launches Innovative E-Book: “Realistic Ways to Make More Money in 30 Days” 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:H Miracle Review Exposes Natural Method to Cure Hemorrhoids 2Health News:One Minute to Herpes Cure Review Reveals Simplest Herpes Treatment 2
... hospitals and health care clinics in China have been ... be prepared to handle cases. //The Ministry of Health ... unusual rise in diarrhea cases. ,As Norovirus ... caution while eating in restaurants and hotels. These viruses ...
... sketched out an action plan to bring down the HIV ... will be allotted to implement a series of programmes towards ... this campaign, the Aboriginal and Torres Strait Islander community would ... practitioners, information related to HIV prevention also will be circulated. ...
... health of Cuban leader Fidel Castro has deteriorated following ... Pais reported Tuesday.// ,Castro is in 'very grave' ... intestinal infection, El Pais said citing sources from the ... Sabrido. ,Sabrido, chief surgeon at the Gregorio ...
... the benefits of tomato and broccoli in the management of ... vegetables, are a great blessing in the reduction of tumors,// ... ,It is estimated that one out of four ... the most notorious of male cancers. Annually, 32,000 cases are ...
... have found that a score that measures the proteomic ... // ,Researchers from Yale University, led by Catalin ... markers that were closely associated with inflammation in the ... proteins?€the "Mass Restricted" (MR) score. This score has been ...
... - there is no proof for growth hormone therapy’s anti-aging ... University, after analyzing 31 scientific papers based on growth hormone.// ... suggest that giving growth hormone to an otherwise healthy person ... however, that there was substantial potential for adverse side effects.' ...
Cached Medicine News:Health News:Tomato and Broccoli Combo may Help Fight Prostate Cancer 2Health News:Is Growth Hormone – a Key to Longevity 2
(Date:7/29/2014)... and NEW YORK , ... of the executive management team of Caremark Rx, ... Media ( www.pbm365.com ).  PBM365 is the leading independent ... reporting, insight, analysis and opinion on the pharmacy ... will provide insightful and timely coverage of, and context ...
(Date:7/29/2014)... 2014 According to a new ... Fixation Devices Market - Global Forecast, Market Share, Size, ... orthopedic trauma fixation devices market is estimated at USD ... at a CAGR of 7.2% from 2014 to 2019, ... in 2020. Browse the Orthopedic Trauma Fixation ...
(Date:7/29/2014)... -- Research and Markets has announced the ... report to their offering. ... a medical device used to provide medication or assist ... cannot achieve adequate oxygen levels to maintain life. Patients ... and ARDS require the need of respiratory devices. The ...
Breaking Medicine Technology:Drew Crawford Announces Launch of PBM365 Media 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4Global Respiratory Devices Market 2014-2018 2
... May 19 A meta-analysis of approximately ... The Lancet on May 1, 2010 ... phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme, are associated ... in magnitude to that with non-HDL cholesterol or systolic ...
... SAN FRANCISCO , May 19 ... trials evaluating Ferring Pharmaceuticals, LYSTEDA™ (tranexamic acid) tablets, a ... with cyclic heavy menstrual bleeding (HMB), were presented at ... Clinical Meeting in San Francisco , May ...
Cached Medicine Technology:Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 2Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 3Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 2Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 3Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 4Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 5Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 6
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: